Compartmentalization of β-adrenergic signals in cardiomyocytes

Trends in Cardiovascular Medicine

Volumn 23, Issue 7, 2013, Pages 250-256

  Fu, Qin ^a,b   Chen, Xiongwen ^c   Xiang, Yang K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; NEUROHORMONE; PHOSPHODIESTERASE;

BETA ADRENERGIC STIMULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMPARTMENTATION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; MODELS, BIOLOGICAL; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PHOSPHORYLATION; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION;

EID: 84883759198     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2013.02.001     Document Type: Review

References (56)

1. Agarwal S.R., MacDougall D.A., Tyser R., Pugh S.D., Calaghan S.C., Harvey R.D. Effects of cholesterol depletion on compartmentalized cAMP responses in adult cardiac myocytes. Journal of Molecular and Cellular Cardiology 2011, 50:500-509.
2. Anderson M.E., Brown J.H., Bers D.M. CaMKII in myocardial hypertrophy and heart failure. Journal of Molecular and Cellular Cardiology 2011, 51:468-473.
3. Balijepalli R.C., Foell J.D., Hall D.D., Hell J.W., Kamp T.J. Localization of cardiac L-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:7500-7505.
4. Barbuti A., Terragni B., Brioschi C., DiFrancesco D. Localization of f-channels to caveolae mediates specific beta2-adrenergic receptor modulation of rate in sinoatrial myocytes. Journal of Molecular and Cellular Cardiology 2007, 42:71-78.
5. 2+ current. Circulation Research 2011, 109:1024-1030.
6. Calebiro D., Nikolaev V.O., Persani L., Lohse M.J. Signaling by internalized G-protein-coupled receptors. Trends in Pharmacological Sciences 2010, 31:221-228.
7. De Arcangelis V., Liu R., Soto D., Xiang Y. Differential association of phosphodiesterase 4D isoforms with beta2-adrenoceptor in cardiac myocytes. The Journal of Biological Chemistry 2009, 284:33824-33832.
8. De Arcangelis V., Liu S., Zhang D., Soto D., Xiang Y.K. Equilibrium between adenylyl cyclase and phosphodiesterase patterns adrenergic agonist dose-dependent spatiotemporal cAMP/protein kinase A activities in cardiomyocytes. Molecular Pharmacology 2010, 78:340-349.
9. De Arcangelis V., Soto D., Xiang Y. Phosphodiesterase 4 and phosphatase 2A differentially regulate cAMP/protein kinase a signaling for cardiac myocyte contraction under stimulation of beta1 adrenergic receptor. Molecular Pharmacology 2008, 74:1453-1462.
10. Di Benedetto G., Zoccarato A., Lissandron V., Terrin A., Li X., Houslay M.D., et al. Protein kinase A type I and type II define distinct intracellular signaling compartments. Circulation Research 2008, 103:836-844.
11. Dodge K.L., Khouangsathiene S., Kapiloff M.S., Mouton R., Hill E.V., Houslay M.D., et al. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. The EMBO Journal 2001, 20:1921-1930.
12. Dodge-Kafka K.L., Bauman A., Mayer N., Henson E., Heredia L., Ahn J., et al. cAMP-stimulated protein phosphatase 2A activity associated with muscle A kinase-anchoring protein (mAKAP) signaling complexes inhibits the phosphorylation and activity of the cAMP-specific phosphodiesterase PDE4D3. The Journal of Biological Chemistry 2010, 285:11078-11086.
13. Eschenhagen T., Mende U., Nose M., Schmitz W., Scholz H., Haverich A., et al. Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure. Circulation Research 1992, 70:688-696.
14. 2+ release kinetics during beta-adrenergic stimulation. Journal of Molecular and Cellular Cardiology 2007, 43:281-291.
15. Gao M., Ping P., Post S., Insel P.A., Tang R., Hammond H.K. Increased expression of adenylylcyclase type VI proportionately increases β-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:1038-1043.
16. Lader A.S., Xiao Y.F., Ishikawa Y., Cui Y., Vatner D.E., Vatner S.F., et al. Cardiac Gsalpha overexpression enhances L-type calcium channels through an adenylyl cyclase independent pathway. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:9669-9674.
17. Lee D.I., Vahebi S., Tocchetti C.G., Barouch L.A., Solaro R.J., Takimoto E., et al. PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation. Basic Research in Cardiology 2010, 105:337-347.
18. Lefkowitz R.J. Seven transmembrane receptors: something old, something new. Acta Physiologica (Oxford, England) 2007, 190:9-19.
19. Lehnart S.E., Wehrens X.H., Reiken S., Warrier S., Belevych A.E., Harvey R.D., et al. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 2005, 123:25-35.
20. Liu R., Wang D., Shi Q., Fu Q., Hizon S., Xiang Y.K. Palmitoylation regulates intracellular trafficking of beta2 adrenergic receptor/arrestin/phosphodiesterase 4D complexes in cardiomyocytes. PLoS One 2012, 7:e42658.
21. Liu S., Li Y., Kim S., Fu Q., Parikh D., Sridhar B., et al. Phosphodiesterases coordinate cAMP propagation induced by two stimulatory G protein-coupled receptors in hearts. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:6578-6583.
22. 2+ re-uptake into heart sarcoplasmic reticulum. EMBO Reports 2007, 8:1061-1067.
23. Macdougall D.A., Agarwal S.R., Stopford E.A., Chu H., Collins J.A., Longster A.L., et al. Caveolae compartmentalise beta2-adrenoceptor signals by curtailing cAMP production and maintaining phosphatase activity in the sarcoplasmic reticulum of the adult ventricular myocyte. Journal of Molecular and Cellular Cardiology 2012, 52:388-400.
24. Masunaga R., Nagasaka A., Sawai Y., Hayakawa N., Nakai A., Hotta K., et al. Changes in cyclic nucleotide phosphodiesterase activity and calmodulin concentration in heart muscle of cardiomyopathic hamsters. Journal of Molecular and Cellular Cardiology 2004, 37:767-774.
25. Mongillo M., McSorley T., Evellin S., Sood A., Lissandron V., Terrin A., et al. Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases. Circulation Research 2004, 95:67-75.
26. Mongillo M., Tocchetti C.G., Terrin A., Lissandron V., Cheung Y.F., Dostmann W.R., et al. Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway. Circulation Research 2006, 98:226-234.
27. Nichols C.B., Rossow C.F., Navedo M.F., Westenbroek R.E., Catterall W.A., Santana L.F., et al. Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels. Circulation Research 2010, 107:747-756.
28. Nikolaev V.O., Bunemann M., Schmitteckert E., Lohse M.J., Engelhardt S. Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling. Circulation Research 2006, 99:1084-1091.
29. Nikolaev V.O., Moshkov A., Lyon A.R., Miragoli M., Novak P., Paur H., et al. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 2010, 327:1653-1657.
30. 2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II. The Journal of Biological Chemistry 2009, 284:1514-1522.
31. Okumura S., Kawabe J., Yatani A., Takagi G., Lee M.C., Hong C., et al. Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation. Circulation Research 2003, 93:364-371.
32. Perino A., Ghigo A., Scott J.D., Hirsch E. Anchoring proteins as regulators of signaling pathways. Circulation Research 2012, 111:482-492.
33. Richter W., Day P., Agrawal R., Bruss M.D., Granier S., Wang Y.L., et al. Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4. The EMBO Journal 2008, 27:384-393.
34. Richter W., Xie M., Scheitrum C., Krall J., Movsesian M.A., Conti M. Conserved expression and functions of PDE4 in rodent and human heart. Basic Research in Cardiology 2011, 106:249-262.
35. Russel F.G., Koenderink J.B., Masereeuw R. Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. Trends in Pharmacological Sciences 2008, 29:200-207.
36. Russell M.A., Lund L.M., Haber R., McKeegan K., Cianciola N., Bond M. The intermediate filament protein, synemin, is an AKAP in the heart. Archives of Biochemistry and Biophysics 2006, 456:204-215.
37. Sellers Z.M., Naren A.P., Xiang Y., Best P.M. MRP4 and CFTR in the regulation of cAMP and beta-adrenergic contraction in cardiac myocytes. European Journal of Pharmacology 2012, 681:80-87.
38. Sette C., Conti M. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation. The Journal of Biological Chemistry 1996, 271:16526-16534.
39. Soltis A.R., Saucerman J.J. Synergy between CaMKII substrates and beta-adrenergic signaling in regulation of cardiac myocyte Ca(2+) handling. Biophysical Journal 2010, 99:2038-2047.
40. Soto D., De Arcangelis V., Zhang J., Xiang Y. Dynamic protein kinase a activities induced by beta-adrenoceptors dictate signaling propagation for substrate phosphorylation and myocyte contraction. Circulation Research 2009, 104:770-779.
41. Stangherlin A., Zaccolo M. cGMP-cAMP interplay in cardiac myocytes: a local affair with far-reaching consequences for heart function. Biochemical Society Transactions 2012, 40:11-14.
42. Sumandea C.A., Garcia-Cazarin M.L., Bozio C.H., Sievert G.A., Balke C.W., Sumandea M.P. Cardiac troponin T, a sarcomeric AKAP, tethers protein kinase A at the myofilaments. The Journal of Biological Chemistry 2011, 286:530-541.
43. Swaminathan P.D., Purohit A., Hund T.J., Anderson M.E. Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. Circulation Research 2012, 110:1661-1677.
44. Tao J., Malbon C.C. G-protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: differential signaling to MAPK and GPCR recycling. Journal of Molecular Signaling 2008, 3:19.
45. Uys G.M., Ramburan A., Loos B., Kinnear C.J., Korkie L.J., Mouton J., et al. Myomegalin is a novel A-kinase anchoring protein involved in the phosphorylation of cardiac myosin binding protein C. BMC Cell Biology 2011, 12:18.
46. Warrier S., Belevych A.E., Ruse M., Eckert R.L., Zaccolo M., Pozzan T., et al. Beta-adrenergic- and muscarinic receptor-induced changes in cAMP activity in adult cardiac myocytes detected with FRET-based biosensor. American Journal of Physiology. Cell Physiology 2005, 289:C455-C461.
47. Willoughby D., Wong W., Schaack J., Scott J.D., Cooper D.M. An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics. The EMBO Journal 2006, 25:2051-2061.
48. Xiang Y., Devic E., Kobilka B. The PDZ binding motif of the beta 1 adrenergic receptor modulates receptor trafficking and signaling in cardiac myocytes. The Journal of Biological Chemistry 2002, 277:33783-33790.
49. Xiang Y., Naro F., Zoudilova M., Jin S.L., Conti M., Kobilka B. Phosphodiesterase 4D is required for {beta}2 adrenoceptor subtype-specific signaling in cardiac myocytes. Proceedings of the National Academy of Sciences of the United States of America 2005.
50. Xiang Y.K. Compartmentalization of beta-adrenergic signals in cardiomyocytes. Circulation Research 2011, 109:231-244.
51. 2+ dynamics, contractility, or phospholamban phosphorylation. The Journal of Biological Chemistry 1994, 269:19151-19156.
52. Yin X., Cuello F., Mayr U., Hao Z., Hornshaw M., Ehler E., et al. Proteomics analysis of the cardiac myofilament subproteome reveals dynamic alterations in phosphatase subunit distribution. Molecular & Cellular Proteomics: MCP 2010, 9:497-509.
53. Zaccolo M. Phosphodiesterases and compartmentalized cAMP signalling in the heart. European Journal of Cell Biology 2006, 85:693-697.
54. Zaccolo M., Pozzan T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 2002, 295:1711-1715.
55. Zhang R., Khoo M.S., Wu Y., Yang Y., Grueter C.E., Ni G., et al. Calmodulin kinase II inhibition protects against structural heart disease. Nature Medicine 2005, 11:409-417.
56. 2+/calmodulin kinase II. The Journal of Clinical Investigation 2003, 111:617-625.